Kyverna Therapeutics, Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KYTX and other ETFs, options, and stocks.About KYTX
Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.
CEOWarner Biddle
CEOWarner Biddle
Employees112
Employees112
HeadquartersEmeryville, California
HeadquartersEmeryville, California
Founded2018
Founded2018
Employees112
Employees112
KYTX Key Statistics
Market cap89.25M
Market cap89.25M
Price-Earnings ratio-0.61
Price-Earnings ratio-0.61
Dividend yield—
Dividend yield—
Average volume294.50K
Average volume294.50K
High today—
High today—
Low today—
Low today—
Open price$2.27
Open price$2.27
Volume0.00
Volume0.00
52 Week high$17.06
52 Week high$17.06
52 Week low$1.78
52 Week low$1.78
Analyst ratings
83%
of 6 ratingsBuy
83.3%
Hold
16.7%
Sell
0%
People also own
Based on the portfolios of people who own KYTX. This list is generated using Robinhood data, and it’s not a recommendation.